Effects of Dietary Phosphorus Restriction on Secondary Hyperparathyroidism in Hemodialysis Patients During Intermittent Oral High-Dose 1, 25(OH)2D3 Treatment

Journal of Nutritional Science and Vitaminology - Japan
doi 10.3177/jnsv.37.supplement_s105
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Center for Academic Publications Japan

Related search

Intermittent Dosing of Cinacalcet Is Also Effective in Treating Secondary Hyperparathyroidism in Hemodialysis Patients

Pharmaceutica Analytica Acta
2013English

Effects of Maxacalcitol on Bone Metabolic Markers in Hemodialysis Patients With Secondary Hyperparathyroidism

Nihon Toseki Igakkai Zasshi
2004English

Effect of 22-Oxacalcitriol on Secondary Hyperparathyroidism in Hemodialysis Patients

Internal Medicine
Internal MedicineMedicine
2003English

Nutritional Status of Hemodialysis Patients With Secondary Hyperparathyroidism

Brazilian Journal of Medical and Biological Research
ImmunologyCell BiologyPharmacologyBiochemistryBiophysicsNeuroscienceMedicineToxicologyPhysiologyPharmaceutics
2000English

Erratum To: Calcitriol Resistance in Hemodialysis Patients With Secondary Hyperparathyroidism

International Urology and Nephrology
UrologyNephrology
2014English

Clinical Efficacy of 22-Oxacalcitriol Against Secondary Hyperparathyroidism in Hemodialysis Patients.

Nihon Toseki Igakkai Zasshi
1999English

Vitamin D Receptor Expression Is Essential During Retinal Vascular Development and Attenuation of Neovascularization by 1, 25(OH)2D3

PLoS ONE
Multidisciplinary
2017English

1, 25(OH)2D3 Inhibits Hepatocellular Carcinoma Development Through Reducing Secretion of Inflammatory Cytokines From Immunocytes

Current Medicinal Chemistry
Organic ChemistryBiochemistryDrug DiscoveryMolecular MedicinePharmacology
2013English

Vitamin-D3 (Α-1, 25(OH) 2D3) Protects Retinal Pigment Epithelium From Hyperoxic Insults

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy